S. Paniga

415 total citations
7 papers, 355 citations indexed

About

S. Paniga is a scholar working on Molecular Biology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, S. Paniga has authored 7 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in S. Paniga's work include Blood Coagulation and Thrombosis Mechanisms (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). S. Paniga is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). S. Paniga collaborates with scholars based in Italy. S. Paniga's co-authors include Angela D’Angelo, Arrigo F.G. Cicero, Giuseppe Derosa, Sibilla Salvadeo, Alessia Gravina, Leonardina Ciccarelli, F. Pricolo, Carmine Tinelli, Lorenza Montagna and Mario N. Piccinni and has published in prestigious journals such as Journal of Cardiovascular Pharmacology, Diabetes & Metabolism and Journal of Clinical Pharmacy and Therapeutics.

In The Last Decade

S. Paniga

7 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Paniga Italy 6 136 127 91 90 69 7 355
Eleonora Devangelio Italy 6 121 0.9× 85 0.7× 56 0.6× 109 1.2× 50 0.7× 6 387
Chihiro Horimai Japan 7 81 0.6× 155 1.2× 47 0.5× 61 0.7× 41 0.6× 9 378
Jessica Smith United Kingdom 10 83 0.6× 150 1.2× 54 0.6× 78 0.9× 41 0.6× 17 341
M. Sai Babu India 9 61 0.4× 93 0.7× 50 0.5× 99 1.1× 41 0.6× 10 361
Kiriko Wada Japan 11 138 1.0× 146 1.1× 39 0.4× 54 0.6× 59 0.9× 21 413
A.K.M. Tarikuz Zaman United States 11 57 0.4× 89 0.7× 41 0.5× 191 2.1× 74 1.1× 26 349
Johnny Nehmé France 9 150 1.1× 110 0.9× 17 0.2× 155 1.7× 95 1.4× 10 478
Michele D’ Amico Italy 8 62 0.5× 158 1.2× 40 0.4× 95 1.1× 36 0.5× 8 311
Jacy R. Crosby United States 4 212 1.6× 76 0.6× 77 0.8× 91 1.0× 234 3.4× 6 465
Stefan‐Martin Brand‐Herrmann Germany 12 127 0.9× 190 1.5× 36 0.4× 194 2.2× 56 0.8× 22 470

Countries citing papers authored by S. Paniga

Since Specialization
Citations

This map shows the geographic impact of S. Paniga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Paniga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Paniga more than expected).

Fields of papers citing papers by S. Paniga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Paniga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Paniga. The network helps show where S. Paniga may publish in the future.

Co-authorship network of co-authors of S. Paniga

This figure shows the co-authorship network connecting the top 25 collaborators of S. Paniga. A scholar is included among the top collaborators of S. Paniga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Paniga. S. Paniga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Derosa, Giuseppe, Angela D’Angelo, P. D. Ragonesi, et al.. (2007). Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. Internal Medicine Journal. 37(2). 79–86. 37 indexed citations
2.
Derosa, Giuseppe, Angela D’Angelo, Carmine Tinelli, et al.. (2007). Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes & Metabolism. 33(2). 129–134. 110 indexed citations
3.
Derosa, Giuseppe, Arrigo F.G. Cicero, Angela D’Angelo, et al.. (2006). Effect of Doxazosin on C-Reactive Protein Plasma Levels and on Nitric Oxide in Patients With Hypertension. Journal of Cardiovascular Pharmacology. 47(4). 508–512. 6 indexed citations
4.
Derosa, Giuseppe, Angela D’Angelo, P. D. Ragonesi, et al.. (2006). Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. Journal of Clinical Pharmacy and Therapeutics. 31(4). 375–383. 72 indexed citations
5.
Derosa, Giuseppe, Arrigo F.G. Cicero, Angela D’Angelo, et al.. (2006). Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy. High Blood Pressure & Cardiovascular Prevention. 13(2). 47–52. 1 indexed citations
6.
Derosa, Giuseppe, Angela D’Angelo, P. D. Ragonesi, et al.. (2006). Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. Journal of International Medical Research. 34(5). 545–555. 18 indexed citations
7.
Derosa, Giuseppe, Angela D’Angelo, Leonardina Ciccarelli, et al.. (2006). Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension. Endothelium. 13(3). 227–231. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026